Untranslated

More Language

86-21-64556180

cpd-service@caerulumpharma.com

Kumba
Nezvedu
Products
Solutions
Zviwanikwa
- Downloadable
- Image gallery
FAQs
Taura nesu

Kumba
Products
Bioactive mamorekuru
Vamwe
Influenza virus

Products Categories

Antineoplastic
- ACC
- Adenosine A2A
- ALK
- Androgen receptor inhibitor
- Apoptosis stimulant
- ATR
- AXL
- BCl2-BH4
- Bcr-Abl
- BRAF
- BTK
- CDK
- Chk1
- CYP17
- DNA alkylating agent
- EED
- EGFR
- EP4
- ER
- FAK
- FGFR
- FLT3
- Glutaminase
- NDINO
- IRA
- KIT
- LXR
- MDM2
- MEK
- MET
- Nrf2
- P90RSK
- P97
- PAKS
- PARP
- PI3K
- Plk-1
- SMYD2
- SRC
- TOPK
- VEGFR
Hypoglycemic drugs
- DPP-4
- SGLT-1
- SGLT-2
Vamwe
- 5HT
- AMPK
- Arginase
- CRF-1
- CXCR2
- FLAP
- FXR
- GABA
- Gi activator
- GR
- JAK
- LABA
- mAChRs
- NF-κB
- NRTI
- PPAR
- RIP1
- S1PR
- SGC
- SYK
- α2δ-1
- αIIbβ3
- β2-adrenoceptor
- σ1

Influenza virus

CAT #	Product Name	Tsanangudzo
CPD2051	Baloxavir	Baloxavir ianti-furuwenza agent yakatorwa kubva patent WO 2017104691 A1.

...

Taura nesu

Nhamba 401, 4th Floor, Building 6, Quwu Road 589, Minhang District, 200241 Shanghai, China
86-21-64556180
MuChina:
sales-cpd@caerulumpharma.com
International:
cpd-service@caerulumpharma.com

Inquiry

Kuti uwane kubvunza nezve zvigadzirwa zvedu, ndapota siya email yako nesu uye isu tichabatana mukati memaawa makumi maviri nemana.Inquiry

Latest News

AstraZeneca inogamuchira kukwidziridzwa kwemishonga yeoncology

AstraZeneca inogamuchira kukwidziridzwa kwe ...

AstraZeneca yakagamuchira kukwidziridzwa kwakapetwa kaviri kweiyo oncology portfolio neChipiri, mushure mekunge US neEuropean regulators vabvuma kutumirwa kwemishonga yavo, danho rekutanga rekuhwina mvumo yemishonga iyi. ...

Pamusoro 7 Trends MuKutsvaga Kwemishonga Muna 2018

Epamusoro 7 Mafambiro Mukutsvakurudza Kwemishonga Ini...

Kuve pasi pekumanikidzwa kunoramba kuchiwedzera kukwikwidza munzvimbo yakaoma yehupfumi uye tekinoroji, makambani emishonga uye ebiotech anofanirwa kuramba achivandudza muzvirongwa zvavo zveR&D kuti varambe vari mberi ...

ARS-1620: Inovimbisa inhibitor itsva yeKRAS-mutant cancers

ARS-1620: Inhibitor itsva inovimbisa yeK...

Zvinoenderana neongororo yakaburitswa muSero, vaongorori vakagadzira chaiyo inhibitor yeKRASG12C inonzi ARS-1602 iyo yakakonzera kudzoka kwebundu mumakonzo. "Chidzidzo ichi chinopa in vivo humbowo hwekuti mutant KRAS inogona ...

AstraZeneca inogamuchira kukwidziridzwa kwemishonga yeoncology

AstraZeneca inogamuchira kukwidziridzwa kwe ...

AstraZeneca yakagamuchira kukwidziridzwa kwakapetwa kaviri kweiyo oncology portfolio neChipiri, mushure mekunge US neEuropean regulators vabvuma kutumirwa kwemishonga yavo, danho rekutanga rekuhwina mvumo yemishonga iyi. ...

Pamusoro 7 Trends MuKutsvaga Kwemishonga Muna 2018

Epamusoro 7 Mafambiro Mukutsvakurudza Kwemishonga Ini...

Kuve pasi pekumanikidzwa kunoramba kuchiwedzera kukwikwidza munzvimbo yakaoma yehupfumi uye tekinoroji, makambani emishonga uye ebiotech anofanirwa kuramba achivandudza muzvirongwa zvavo zveR&D kuti varambe vari mberi ...

prev

next

© Copyright - 2015-2022 : All Rights Reserved.

FAQs
Downloadable
Taura nesu

QR Code

WhatsApp Online Chat !

TOP

Previous Maximize